Stimulatory and inhibitory cyclic AMP responses in rabbit ciliary processes after cervical ganglionectomy

References

• Sears M. L. Autonomic nervous system: adrenergic agonists. “Handbook of Experimental Pharmacology”. Vol. 69, M. L. Sears. Springer-Verlag, Berlin, HeidelbergGermany 1984; 193–248
   Google Scholar
• Sears M., Gregory D., Bausher L., Mishina H., Stjernschantz J. A receptor for aqueous humor formation. “New Directions in Ophthalmic Research”, M. L. Sears. Yale University Press, New Haven, CT 1981; 163–183
   Google Scholar
• Mishima S. Ocular effects of beta-adrenergic agents. Surv. Ophthalmol. 1982; 27: 187–208
   PubMed Web of Science ®Google Scholar
• Potter D. E. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol. Rev. 1981; 33: 133–153
   PubMed Web of Science ®Google Scholar
• Neufeld A. H. The mechanism of action of adrenergic drugs in the eye. “Glaucoma: Applied Pharmacology in Medical Treatment”, S. M. Drance, A. H. Neufeld. Grune & Stratton, Inc., Orlando, PL. 1984; 277–301
   Google Scholar
• Sears M. L. Regulation of aqueous flow by the adenylate cyclase receptor complex in the ciliary epithelium. Am. J. Ophthalmol. 1985; 100: 194–198
   PubMed Web of Science ®Google Scholar
• Burstein N. L., Sears M. L., Mead A. Aqueous flow in human eyes is reduced by forskolln, a potent adenylate cyclase activator. Exp. Eye Res. 1984; 39: 745–749
   PubMed Web of Science ®Google Scholar
• Bartels S. P., Lee S. R., Neufeld A. H. The effects of forskolin on cyclic AMP, intraocular pressure and aqueous humor formation in rabbits. Curr. Eye Res. 1987; 6: 307–320
   PubMed Web of Science ®Google Scholar
• Lee P.-Y., Podos S. M., Mittag T., Severin C. Effect of topically applied forskolln on aqueous humor dynamics in cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 1984; 25: 1206–1209
   PubMed Web of Science ®Google Scholar
• Caprioli J., Sears M., Bausher L., Gregory D., Mead A. Forskolln lowers intraocular pressure by reducing aqueous flow. Invest. Ophthalmol. Vis. Sci. 1984; 25: 268–277
   PubMed Web of Science ®Google Scholar
• Waitzman M. B., Woods V. D. Some characteristics of an adenyl cyclase preparation fron rabbit ciliary process tissue. Exp. Eye Res. 1971; 12: 99–111
   PubMedGoogle Scholar
• Neufeld A. H., Sears H. L. Cyclic-AMP in ocular tissues of the rabbit, monkey, and human. Invest. Ophthalmol. 1974; 12: 475–477
   Google Scholar
• Bromberg B. B., Gregory D. S., Sears H. L. Beta-adrenergic receptors in ciliary processes of the rabbit. Invest. Ophthalmol. Vis. Sci. 1980; 11: 203–207
   Google Scholar
• Nathanson J. A. Adrenergic regulation of Intraocular pressure: Identification of betaz-adrenergic-stlmulated adenylate cyclase in ciliary process epithelium. Proc. Mat'l. Acad. Sci., USA 1980; 77: 7420–7424
   PubMed Web of Science ®Google Scholar
• Cepelik J., Cernohorsky M. The effects of adrenergic agonists and antagonists on the adenylate cyclase in albino rabbit ciliary processes. Exp. Eye Res. 1981; 21: 291–299
   Google Scholar
• Elena P. P., Predj-Reygrobellet D., Moulin G., Lapalus P. Pharmacological characteristics of beta-adrenerglc-sensitive adenylate cyclase in non pigmented and in pigmented cells of bovine ciliary process. Curr. Eye Res. 1984; 3: 1383–1389
   PubMed Web of Science ®Google Scholar
• Hittag T. V., Tormay A. Drug responses of adenylate cyclase in iris-ciliary body determined by adenine labelling. Invest. Ophthalmol. Vis. Sci. 1985; 26: 396–399
   PubMedGoogle Scholar
• De Vries G. V., Mobasser A., Wheeler L. A. Stimulation of endogenous cyclic AMP levels in ciliary body by SK&F 82526, a novel dopamine receptor agonist. Curr. Eye Res. 1986; 5: 449–455
   PubMed Web of Science ®Google Scholar
• Mittag T. V., Tormay A., Podos S. M. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. J. Pharmacol. Exp. Therap. 1987; 241: 230–235
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Gregory D. S., Sears H. L. Interaction between alphas- and betai-adrenergic receptors in rabbit ciliary processes. Curr. Eye Res. 1987; 6: 497–505
   PubMed Web of Science ®Google Scholar
• Bausher I. P., Gregory D. S., Sears H. L. Alphaz-adrenergic and VIP receptors in rabbit ciliary processes interact. Curr. Eye Res. 1989; 8: 47–54
   PubMed Web of Science ®Google Scholar
• Klnts P., Himber J., de Burlet G., Andermann G. Characterization of alpha2-adrenergic receptors, negatively coupled to adenylate cyclase, in rabbit ciliary processes. Curr. Eye Res. 1988; 7: 287–292
   PubMedGoogle Scholar
• Jin I., Elko E. E., Tran T., Yorio T. Inhibition of adenylate cyclase in bovine ciliary process and rabbit iris-ciliary body to alphas-adrenergic agonists. J. Oc. Pharmacol. 1989; 5: 189–197
   PubMedGoogle Scholar
• Cepelik J., Hynie S. Inhibitory effects of clonidine and dopamine on adenylate cyclase of rabbit ciliary processes. Curr. Eye Res. 1990; 9: 111–120
   PubMed Web of Science ®Google Scholar
• Cepelik J., Hynie S. Inhibitory effects of neuropeptide Y on adenylate cyclase of rabbit ciliary processes. Curr. Eye Res. 1990; 9: 121–128
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Horio B. Neuropeptide Y and somatostatin inhibit stimulated cyclic AMP production in rabbit ciliary processes. Curr. Eye Res. 1990; 9: 371–378
   PubMed Web of Science ®Google Scholar
• Colasanti B. K., Trotter R. R. Effects of selective beta2- and beta2-adreno-receptor agonists and antagonists on intraocular pressure in the cat. Invest. Ophthalmol. Vis. Sci. 1981; 20: 69–76
   PubMed Web of Science ®Google Scholar
• Gaul A., Mintening G. M., Belmonte C. Intraocular pressure effects of water loading and venous compression tests in normal and denervated pigmented rabbits. Exp. Eye Res. 1989; 48: 365–374
   PubMedGoogle Scholar
• Potter D. E., Burke J. A., Chang F. W. Alteration in ocular function Induced by phenylethylamine analogs of dopamine. Curr. Bye Res. 1984; 3: 851–859
   Google Scholar
• Burke J. A., Potter D. E. Ocular effects of a relatively selective alphas agonist (UK-14,304-18) in cats, rabbits, and monkeys. Curr. Eye Res. 1986; 5: 665–676
   PubMed Web of Science ®Google Scholar
• Burke J. A., Potter D. E. Aporphine derivatives affect ocular function in diverse ways. Curr. Eye Res. 1987; 6: 1227–1236
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., North G. T. Potentiation of sympathetic neurosecretion by fors-kolin and cyclic AMP in the rabbit iris-ciliary body. Curr. Eye Res. 1986; 5: 495–502
   PubMed Web of Science ®Google Scholar
• Jumblatt J. B., Liu J. G.H., North G. T. Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit lris-clliary body. Curr. Eye Res. 1987; 6: 767–777
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., North G. T. Cholinergic inhibition of adrenergic neurosecretion in the rabbit iris-ciliary body. Invest. Ophthalmol. Vis. Sci. 1988; 29: 615–620
   PubMedGoogle Scholar
• Jumblatt J. E., Hackmiller R. C. Potentiation of norepinephrine secretion by angiotensin II in the isolated rabbit iris-ciliary body. Curr. Bye Res. 1990; 9: 169–176
   Google Scholar
• Neufeld A. H., Page E. D. Regulation of adrenergic neuromuscular transmission in the rabbit iris. Exp. Eye Res. 1975; 20: 549–561
   PubMed Web of Science ®Google Scholar
• Liu J. H.K., Bartels S. P., Neufeld A. H. Effects of timolol on intraocular pressure following ocular adrenergic denervation. Curr. Eye Res. 1984; 3: 1113–1117
   PubMed Web of Science ®Google Scholar
• Gregory D. S., Aviado D. G., Sears M. L. Cervical gangllonectomy alters the circadian rhythm of intraocular pressure in Mew Zealand White rabbits. Curr. Eye Res. 1985; 4: 1273–1279
   PubMed Web of Science ®Google Scholar
• Braslow R. A., Gregory D. S. Adrenergic decentralization modifies the circadian rhythm of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 1987; 28: 1730–1732
   PubMed Web of Science ®Google Scholar
• Wentworth W. O., Brubaker R. P. Aqueous humor dynamics is a series of patients with third neuron Horner's syndrome. Am. J. Ophthalmol. 1981; 92: 407–415
   PubMed Web of Science ®Google Scholar
• Larson R. 8., Brubaker R. P. Isoproterenol stimulates aqueous flow in humans with Horner's syndrome. Invest. Ophthalmol. Vis. Sci. 1988; 29: 621–625
   PubMed Web of Science ®Google Scholar
• Thompson H. S., Mensher J. H. Adrenergic mydriasis in Horner's syndrome. Am. J. Ophthalmol. 1971; 72: 472–480
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., North G. T., Hackmiller R. C. Muscarinic cholinergic inhibition of adenylate cyclase in rabbit ciliary processes. Invest. Ophthalmol. Vis. Sci. 1988; 29: 324, Suppl.
   Google Scholar
• Page E. D., Neufeld A. H. Characterization of α- and β-adrenergic receptors in membranes prepared from the rabbit iris before and after development of supersensitivity. Biochem. Pharmacol. 1978; 27: 953–958
   PubMed Web of Science ®Google Scholar
• Neufeld A. H., Chavis R. M., Sears M. L. Cyclic-AMP in the aqueous humor: the effects of repeated topical epinephrine administration and sympathetic denervation. Exp. Eye Res. 1973; 16: 265–272
   PubMed Web of Science ®Google Scholar
• Butler J. M., Ruskell G. L., Cole D. F., Unger H. G., Zhang S. Q., Blank M. A., McGregor G. P., Bloom S. R. Effects of VIIth (facial) nerve degeneration on vasoactive intestinal polypeptide and substance P levels in ocular and orbital tissues of the rabbit. Exp. Eye Res. 1984; 39: 523–532
   PubMed Web of Science ®Google Scholar
• Sporn J. R., Harden T. K., Volfe B. B., Molinoff P. B. β-Adrenergic receptor involvement in 6-hydroxydopamine-lnduced supersensitivity in rat cerebral cortex. Science 1976; 194: 624–626
   PubMed Web of Science ®Google Scholar
• Maguire M. E., Ross E. M., Gilman A. G. β-Adrenergic receptor: ligand binding properties and the interaction vith adenylyl cyclase. Adv. Cyclic Nucleotide Res. 1977; 8: 1–83
   PubMedGoogle Scholar
• Kassls S., Olasmaa M., Terenius L., Fishman P. H. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J. Biol. Chem. 1987; 262: 3429–3431
   PubMedGoogle Scholar
• Barber D. L., Gregor M., Soil A. H. Somatostatin and muscarinic inhibition of canine enteric endocrine cells: cellular mechanisms. Am. J. Physiol. 1987; 253: G684–G689
   Google Scholar
• Owyang C., Viley J. Somatostatin inhibits intestinal motility via modulation of cyclic AMP-dependent cholinergic transmission. “Somatostatin: Basic and Clinical Status”, S. Reichlin. Plenum Press, New York, NY 1987; 253–258
   Google Scholar
• Rodbell M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 1980; 284: 17–22
   PubMed Web of Science ®Google Scholar